Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/E7P stock hub

FRA/E7P has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/E7Pis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.1B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/E7P
In the news

Latest news · FRA/E7P

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.6
P25 n/aP50 n/aP75 n/a
Trailing P/E18.7
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC319.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/E7P market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
181
Groups with data
11
Currency
USD
Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
838
Employees Change
-213%
Employees Change Percent
-20.27
Enterprise value
EUR 4.4B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 4.1B
Price
EUR 33.2
Price currency
EUR
Rev Per Employee
1,343,117.65x
Sic
2834
Symbol
fra/E7P
Website
https://www.indivior.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
5.34%
EV Earnings
20.02x
EV/EBIT
11.05x
EV/EBITDA
10.57x
EV/FCF
-26.28x
EV/Sales
3.99x
FCF yield
-4.07%
Forward P/E
9.56x
P/B ratio
-32.76x
P/E ratio
18.72x
P/S ratio
3.66x
PE Ratio10 Y
30.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
36.12%
EBITDA Margin
36.82%
Gross margin
84.96%
Gross Profit
EUR 950.6M
Gross Profit Growth
12.53%
Gross Profit Growth Q
24.77%
Gross Profit Growth3 Y
11.72%
Gross Profit Growth5 Y
14.13%
Net Income
EUR 218.6M
Net Income Growth Q
89.36%
Net Income Growth5 Y
21.54%
Pretax Margin
22.95%
Profit Margin
19.53%
Profit Per Employee
EUR 262,376
ROA
22.65
Roa5y
10.88
ROCE
111.5
ROIC
319.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
225.75%
Cagr3y
22.77%
Cagr5y
30.32%
EPS Growth Q
82.04
EPS Growth5 Y
25.69
Revenue Growth
10.26x
Revenue Growth Q
19.17x
Revenue Growth3 Y
10.85x
Revenue Growth5 Y
13.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 1
Assets
EUR 1B
Cash
EUR 151.8M
Current Assets
EUR 565.6M
Current Liabilities
EUR 660.6M
Debt
EUR 441.5M
Debt EBITDA
EUR 1.05
Debt FCF
EUR -2.65
Equity
EUR -124.9M
Interest Coverage
11.65
Liabilities
EUR 1.2B
Long Term Assets
EUR 472.6M
Long Term Liabilities
EUR 502.5M
Net Cash
EUR -289.7M
Net Cash By Market Cap
EUR -7.08
Net Debt EBITDA
EUR 0.7
Tangible Book Value
EUR -126.6M
Tangible Book Value Per Share
EUR -1.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.86
Inventory Turnover
1.23
Net Working Capital
EUR -241.1M
Quick ratio
0.59
Working Capital
EUR -97.1M
Working Capital Turnover
EUR -9.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
3.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

33
MetricValue
1Y total return
225.49%
200-day SMA
22.84
3Y total return
85.06%
50-day SMA
27.7
50-day SMA vs 200-day SMA
50over200
5Y total return
275.78%
All Time High
34
All Time High Change
-2.35%
All Time High Date
2026-05-07
All Time Low
5.55
All Time Low Change
498.74%
All Time Low Date
2021-01-07
ATR
0.9
Ch YTD
10.67
High
33.2
High52
34
High52 Date
2026-05-07
High52ch
-2.35%
Low
33.2
Low52
9.75
Low52 Date
2025-05-15
Low52ch
240.51%
Ma50ch
19.86%
Price vs 200-day SMA
45.34%
RSI
70.84
RSI Monthly
72.3
RSI Weekly
76.01
Sharpe ratio
2.74x
Sortino ratio
5.46
Total Return
3.1%
Tr YTD
10.67
Tr1m
27.69%
Tr3m
15.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 404.2M
Operating Income Growth
61.81
Operating Income Growth Q
117.9
Operating Income Growth3 Y
26.91
Operating Income Growth5 Y
27.93
Operating margin
36.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
103,775,994%
Net Borrowing
121,258,566
Shares Insiders
3.73%
Shares Institutions
90.76%
Shares Qo Q
-0.09%
Short Ratio
5.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
EUR -191.7M
Average Volume
29x
Bv Per Share
-1.02
CAPEX
EUR -70.3M
Ch1m
27.69
Ch1y
225.5
Ch3m
15.44
Ch3y
85.06
Ch5y
275.8
Ch6m
26.72
Change
-1.78%
Change From Open
0
Close
33.8
Days Gap
-1.78
Depreciation Amortization
7,631,658
Dollar Volume
664
Earnings Date
2026-04-30
EBIT
EUR 404.2M
EBITDA
EUR 412M
EPS
EUR 1.69
F Score
4
FCF
EUR -166.5M
FCF EV Yield
-3.81x
Financing CF
-5,203,800
Fiscal Year End
December
Founded
2,014
Income Tax
EUR 38.2M
Investing CF
-69,384,000
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2022-10-10
Last Split Type
Reverse
Lynch Fair Value
EUR 38.21
Lynch Upside
15.08
Ma150
26.41
Ma150ch
25.73%
Ma20
29.24
Ma20ch
13.54%
Net CF
-170,858,100
Next Earnings Date
2026-07-30
Open
33.2
Ppne
151,785,198
Price Date
2026-05-08
Price EBITDA
EUR 9.93
Relative Volume
0.69x
Revenue
1,118,817,000x
SBC By Revenue
2.25x
Share Based Comp
25,151,700
Tax By Revenue
3.41x
Tax Rate
14.86%
Tr6m
26.72%
Volume
20
Z Score
3.26
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/E7P pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/E7P stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+225.5%
S&P 500 1Y: n/a
3Y total return
+85.1%
S&P 500 3Y: n/a
5Y total return
+275.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/E7P?

Insider, institutional, and short-interest positioning.

Institutional ownership
+90.8%
Share of float held by funds and institutions
Insider ownership
+3.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
5.3 days to cover
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

FRA/E7P momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.8
Above 70: short-term overbought
Price vs 200-day MA
+45.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
2.74
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/E7P

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/E7P stock rating?

fra/E7P is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/E7P analysis?

The full report lives at /stocks/fra/E7P/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/E7P?

The latest report frames fra/E7P around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/E7P page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/E7P stock profile: metrics, valuation and analysis | Agent AI Rynku Akcji